Physician profile
Ruchi Sharma
NPI 1396900668
$889.96
in general payments reported to CMS, 2019-2025
11 companies · $92.08 in 2025
The $92.08 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $67.52 · 2021: $107 · 2022: $103 · 2023: $136 · 2024: $260 · 2025: $92.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $263.07 | 2020-2025 | Zepbound, Mounjaro |
| Spr Therapeutics, INC | $160.58 | 2023-2024 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.98 | 2019 | |
| Siemens Medical Solutions USA, INC. | $92.95 | 2023 | |
| Vertos Medical, INC. | $84.50 | 2024 | Mild Device Kit |
| Grt US Holding, INC. | $52.29 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $37.07 | 2025 | Iovera |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.41 | 2021 | |
| Glaxosmithkline, LLC. | $19.49 | 2023 | Shingrix, Arexvy |
| Amneal Pharmaceuticals LLC | $16.99 | 2024 | Unithroid |
| Almatica Pharma LLC | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruchi Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.